Since the discovery of statins and the Scandinavian Simvastatin Survival Study (4S) results three decades ago, remarkable advances have been made in the treatment of dyslipidaemia, a major risk factor ...
Dutch clinical-stage biotech NewAmsterdam Pharma, which is focused on non-statin medicines for patients at risk of ...
Altered sphingolipid biosynthetic flux and lipoprotein trafficking contribute to trans fat-induced atherosclerosis - (https:/ ...
A. Many readers have complained about statin side effects like those you mentioned. Two non-statin cholesterol-lowering drugs ...
Two non-statin cholesterol-lowering drugs are PCSK9 inhibitors. They include evolucumab (Repatha) and alirocumab (Praluent). They are injected once or twice a month. Side effects of Repatha may ...
What are non-pharmaceutical ways to lower my cholesterol? " According to the NHS ... while some individuals may require medication like statins, reports Surrey Live. The NHS warns: "Too much ...
In patients who have coronary artery disease, peripheral artery disease or carotid artery disease, there is no question about the benefit of cholesterol-lowering medications such as statins.
New research describes how sphingolipids can also contribute to arterial plaques and atherosclerosis, revealing a new side to ...
Salk scientists have tracked the flow of trans fats using mouse models to describe the molecular mechanisms that cause trans fats to promote atherosclerotic cardiovascular disease (ASCVD), explaining ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback